Confidence intervals associated with tests for bioequivalence
生物等效性检验对应的置信区间AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要属于生物等效性检验与置信区间理论,未提供所列计量领域细分的直接依据。
生物等效性检验对应的置信区间AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Previously, the connection between bioequivalence tests and their associated confidence intervals was not well understood. In fact, the α-level two one-sided tests approach was thought to be associated with a 1−2α confidence interval. In this paper, we build up connections which allow us to construct 1−α confidence intervals from α-level tests and vice versa. When applied to the α-level two one-sided tests, the resultant 1−-α confidence intervals are properly contained in Westlake's 1−-α symmetric interval (1976). Our approach is readily generalized to different settings, including the nonparametric setting, the ratio parameter setting, and the repeated confidence interval setting.